PAS
ARCT icon

Point72 Asia (Singapore)’s Arcturus Therapeutics ARCT Stock Holding History

Point72 Asia (Singapore)’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,005
Closed -$13.1K – 904
2025
Q2 		$13.1K Buy
+1,005
New +$11.9K ﹤0.01% 776
2024
Q4 		– Sell
-61
Closed -$1.43K – 867
2024
Q3 		$1.43K Sell
61
-5,791
-99% -$124K ﹤0.01% 897
2024
Q2 		$142K Buy
+5,852
New +$177K 0.03% 387

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Point72 Asia (Singapore)'s ARCT Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 1,005 shares — an estimated $13.1K sold.

Point72 Asia (Singapore) first reported a position in ARCT in Q2 2024 and held it in 3 quarters. The position peaked at $142K in Q2 2024. 137 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 1,005 Arcturus Therapeutics shares in Q3 2025, an estimated $13.1K.
  • Point72 Asia (Singapore) first reported a position in Arcturus Therapeutics in Q2 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Arcturus Therapeutics position peaked at $142K in Q2 2024.
  • 137 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.